Risk factors and outcomes of cardiovascular disease readmission within the first year after dialysis in peritoneal dialysis patients

被引:13
作者
Li, Jianbo [1 ,2 ]
Huang, Naya [1 ,2 ]
Zhong, Zhong [1 ,2 ]
Joe, Pema [3 ]
Wang, Dan [1 ,2 ]
Ai, Zhen [1 ,2 ]
Wu, Lisha [3 ]
Jiang, Lanping [1 ,2 ]
Huang, Fengxian [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510080, Peoples R China
[2] Natl Hlth Commiss & Guangdong Prov, Key Lab Nephrol, Guangzhou 510080, Peoples R China
[3] Linzhi Peoples Hosp, Dept Med, Linzhi, Peoples R China
基金
中国博士后科学基金;
关键词
Cardiovascular disease readmission; peritoneal dialysis; risk factors; outcomes; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; 30-DAY READMISSION; MORTALITY; ALBUMIN; HOSPITALIZATION; EPIDEMIOLOGY; HEMODIALYSIS; INFLAMMATION; ASSOCIATION;
D O I
10.1080/0886022X.2020.1866009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background In the first year of dialysis, patients are vulnerable to cardiovascular disease (CVD) hospitalization, but knowledge regarding the risk factors and long-term outcomes of cardiovascular readmission within the first year after dialysis in incident continuous ambulatory peritoneal dialysis (CAPD) patients is limited. Methods This retrospective cohort study was conducted in incident CAPD patients. The demographic characteristics, laboratory parameters, and CVD readmission were collected and analyzed. The primary outcome was all-cause mortality, and the secondary outcomes included CVD mortality, infection-related mortality and technique failure. A logistic regression was used to identify the risk factors associated with CVD readmission within the first year after dialysis. Cox proportional hazards models were used to evaluate the association between CVD readmission and the outcomes. Results In total, 1589 peritoneal dialysis (PD) patients were included in this study, of whom 120 (7.6%) patients had at least one episode of CVD readmission within the first year after dialysis initiation. Advanced age, CVD history, and a lower level of serum albumin were independently associated with CVD readmission. CVD readmission within the first year after dialysis was significantly associated with all-cause (HR 2.66, 95%CI 1.91-3.70, p < 0.001) and CVD (HR 3.42, 95%CI 2.20-5.31, p < 0.001) mortality, but not infection-related mortality or technique failure, after adjusting for confounders. Conclusions Our findings suggest that an advanced age, a history of CVD, and a lower level of serum albumin were independently associated with CVD readmission. Moreover, CVD readmission was associated with all-cause and cardiovascular mortality in incident CAPD patients.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 42 条
[1]  
Aguilera Abelardo, 2003, Adv Perit Dial, V19, P240
[2]   Readmission-free period and in-hospital mortality at the time of first readmission in acute heart failure patients-NRD-based analysis of 40,000 heart failure readmissions [J].
Altibi, Ahmed M. ;
Prousi, George ;
Agarwal, Manyoo ;
Shah, Mahek ;
Tripathi, Byomesh ;
Ram, Prathum ;
Patel, Brijesh .
HEART FAILURE REVIEWS, 2021, 26 (01) :57-64
[3]  
[Anonymous], 2016, AM J KIDNEY DIS, DOI DOI 10.1053/J.AJKD.2017.01.036
[4]   National Estimates of 30-Day Unplanned Readmissions of Patients on Maintenance Hemodialysis [J].
Chan, Lili ;
Chauhan, Kinsuk ;
Poojary, Priti ;
Saha, Aparna ;
Hammer, Elizabeth ;
Vassalotti, Joseph A. ;
Jubelt, Lindsay ;
Ferket, Bart ;
Coca, Steven G. ;
Nadkarni, Girish N. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (10) :1652-1662
[5]   Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis [J].
Chan, Lili ;
Poojary, Priti ;
Saha, Aparna ;
Chauhan, Kinsuk ;
Ferrandino, Rocco ;
Ferket, Bart ;
Coca, Steven ;
Nadkarni, Girish ;
Uribarri, Jaime .
CLINICAL KIDNEY JOURNAL, 2017, 10 (04) :552-559
[6]   Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis [J].
Cheng, Li-Tao ;
Tang, Li-Jun ;
Chen, Hui-Min ;
Tang, Wen ;
Wang, Tao .
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (04) :871-876
[7]   End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes [J].
Dai, Lu ;
Golembiewska, Edyta ;
Lindholm, Bengt ;
Stenvinkel, Peter .
EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 :32-43
[8]   High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis [J].
Favari, Elda ;
Thomas, Michael J. ;
Sorci-Thomas, Mary G. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 71 (06) :325-331
[9]   Predictors of 30-Day Hospital Readmission among Maintenance Hemodialysis Patients: A Hospital's Perspective [J].
Flythe, Jennifer E. ;
Katsanos, Suzanne L. ;
Hu, Yichun ;
Kshirsagar, Abhijit V. ;
Falk, Ronald J. ;
Moore, Carlton R. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (06) :1005-1014
[10]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305